Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by L JEFFREY MEDEIROS and PEI LIN.
L JEFFREY MEDEIROS
Connection Strength
7.178
PEI LIN
  1. The impact of MYC rearrangements and "double hit" abnormalities in diffuse large B-cell lymphoma. Curr Hematol Malig Rep. 2013 Sep; 8(3):243-52.
    View in: PubMed
    Score: 0.479
  2. Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. Cancer. 2012 Mar 15; 118(6):1566-73.
    View in: PubMed
    Score: 0.417
  3. JAK2 V617F mutation is uncommon in patients with the 3q21q26 syndrome. Hum Pathol. 2010 May; 41(5):758-62.
    View in: PubMed
    Score: 0.374
  4. Translocation (18;22)(q21;q11) in B-cell lymphomas: a report of 4 cases and review of the literature. Hum Pathol. 2008 Nov; 39(11):1664-72.
    View in: PubMed
    Score: 0.336
  5. Acute myeloid leukemia harboring t(8;21)(q22;q22): a heterogeneous disease with poor outcome in a subset of patients unrelated to secondary cytogenetic aberrations. Mod Pathol. 2008 Aug; 21(8):1029-36.
    View in: PubMed
    Score: 0.333
  6. High-grade B-cell lymphoma/leukemia associated with t(14;18) and 8q24/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis. Haematologica. 2007 Oct; 92(10):1297-301.
    View in: PubMed
    Score: 0.318
  7. Lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia: an evolving concept. Adv Anat Pathol. 2005 Sep; 12(5):246-55.
    View in: PubMed
    Score: 0.275
  8. Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients. Am J Clin Pathol. 2005 Feb; 123(2):200-5.
    View in: PubMed
    Score: 0.264
  9. Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients. Am J Surg Pathol. 2003 Aug; 27(8):1104-13.
    View in: PubMed
    Score: 0.238
  10. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenstr?m macroglobulinemia. Clinicopathologic features of 12 cases. Am J Clin Pathol. 2003 Aug; 120(2):246-53.
    View in: PubMed
    Score: 0.238
  11. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. Am J Surg Pathol. 2000 Nov; 24(11):1480-90.
    View in: PubMed
    Score: 0.197
  12. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma. Am J Surg Pathol. 2015 Sep; 39(9):1250-8.
    View in: PubMed
    Score: 0.137
  13. B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC/BCL2 double-hit lymphomas. Mod Pathol. 2015 Feb; 28(2):208-17.
    View in: PubMed
    Score: 0.128
  14. MYC/BCL2 double-hit high-grade B-cell lymphoma. Adv Anat Pathol. 2013 Sep; 20(5):315-26.
    View in: PubMed
    Score: 0.120
  15. Metastatic splenic angiosarcoma presenting with thrombocytopenia and bone marrow fibrosis mimicking idiopathic thrombocytopenic purpura and primary myelofibrosis: a diagnostic challenge. Clin Lymphoma Myeloma Leuk. 2013 Oct; 13(5):629-33.
    View in: PubMed
    Score: 0.118
  16. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome. Am J Clin Pathol. 2012 Jul; 138(1):146-52.
    View in: PubMed
    Score: 0.110
  17. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation. Hum Pathol. 2012 Nov; 43(11):1828-38.
    View in: PubMed
    Score: 0.109
  18. CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemia. Am J Clin Pathol. 2012 Feb; 137(2):213-9.
    View in: PubMed
    Score: 0.107
  19. Waldenstr?m macroglobulinemia: a review of the entity and its differential diagnosis. Adv Anat Pathol. 2012 Jan; 19(1):11-27.
    View in: PubMed
    Score: 0.107
  20. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome. Mod Pathol. 2012 Jan; 25(1):145-56.
    View in: PubMed
    Score: 0.105
  21. Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia. Am J Clin Pathol. 2011 Aug; 136(2):282-8.
    View in: PubMed
    Score: 0.104
  22. Refractory anemia with ring sideroblasts associated with marked thrombocytosis: a mixed group exhibiting a spectrum of morphologic findings. Am J Clin Pathol. 2011 Mar; 135(3):398-403.
    View in: PubMed
    Score: 0.101
  23. De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification. Mod Pathol. 2011 Mar; 24(3):384-9.
    View in: PubMed
    Score: 0.099
  24. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia. Cancer. 2007 Oct 01; 110(7):1520-6.
    View in: PubMed
    Score: 0.079
  25. Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis. Hum Pathol. 2007 Dec; 38(12):1760-3.
    View in: PubMed
    Score: 0.079
  26. Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24). Cancer Genet Cytogenet. 2007 Aug; 177(1):37-42.
    View in: PubMed
    Score: 0.078
  27. Follicular lymphoma in staging bone marrow specimens: correlation of histologic findings with the results of flow cytometry immunophenotypic analysis. Arch Pathol Lab Med. 2007 Feb; 131(2):282-7.
    View in: PubMed
    Score: 0.076
  28. Activating FLT3 mutations are detectable in chronic and blast phase of chronic myeloproliferative disorders other than chronic myeloid leukemia. Am J Clin Pathol. 2006 Oct; 126(4):530-3.
    View in: PubMed
    Score: 0.074
  29. Expression of B cell-specific activator protein/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22). Am J Clin Pathol. 2006 Aug; 126(2):235-40.
    View in: PubMed
    Score: 0.073
  30. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia. Cancer Genet Cytogenet. 2006 Apr 01; 166(1):82-5.
    View in: PubMed
    Score: 0.072
  31. Acute myeloid leukemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies: a report of four cases and review of the literature. Am J Clin Pathol. 2006 Feb; 125(2):267-72.
    View in: PubMed
    Score: 0.071
  32. Chronic myeloproliferative diseases with the t(5;12)(q33;p13): clonal evolution is associated with blast crisis. Am J Clin Pathol. 2006 Jan; 125(1):49-56.
    View in: PubMed
    Score: 0.070
  33. Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis. Mod Pathol. 2006 Jan; 19(1):25-33.
    View in: PubMed
    Score: 0.070
  34. Extranodal lymphomas of the head and neck. Ann Diagn Pathol. 2005 Dec; 9(6):340-50.
    View in: PubMed
    Score: 0.070
  35. Expression of heat-shock protein-90 in non-Hodgkin's lymphomas. Mod Pathol. 2005 Oct; 18(10):1343-9.
    View in: PubMed
    Score: 0.069
  36. Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type. Br J Haematol. 2005 Sep; 130(5):726-8.
    View in: PubMed
    Score: 0.069
  37. Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenstr?m macroglobulinemia. Am J Clin Pathol. 2005 Sep; 124(3):414-20.
    View in: PubMed
    Score: 0.069
  38. Myeloid sarcoma involving the testis. Am J Clin Pathol. 2005 Sep; 124(3):445-52.
    View in: PubMed
    Score: 0.069
  39. Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia. Am J Clin Pathol. 2005 Jun; 123(6):840-8.
    View in: PubMed
    Score: 0.068
  40. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein. Am J Clin Pathol. 2005 Apr; 123(4):594-602.
    View in: PubMed
    Score: 0.067
  41. Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations. Am J Clin Pathol. 2004 Sep; 122(3):348-58.
    View in: PubMed
    Score: 0.064
  42. The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease. Histopathology. 2004 Jun; 44(6):561-9.
    View in: PubMed
    Score: 0.063
  43. t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia. Am J Clin Pathol. 2004 Jun; 121(6):836-42.
    View in: PubMed
    Score: 0.063
  44. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis. Am J Clin Pathol. 2004 Mar; 121(3):402-7.
    View in: PubMed
    Score: 0.062
  45. Lymphoplasmacytic lymphoma/Waldenstr?m macroglobulinemia associated with Hodgkin disease. A report of two cases. Am J Clin Pathol. 2001 Jul; 116(1):34-40.
    View in: PubMed
    Score: 0.051
  46. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis. Am J Surg Pathol. 2016 Feb; 40(2):253-61.
    View in: PubMed
    Score: 0.035
  47. Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1. Blood. 2015 May 21; 125(21):3360-3.
    View in: PubMed
    Score: 0.034
  48. The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia. Am J Hematol. 2015 Jun; 90(6):504-10.
    View in: PubMed
    Score: 0.033
  49. CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases. Mod Pathol. 2015 Jun; 28(6):787-98.
    View in: PubMed
    Score: 0.033
  50. Double hit lymphoma: the MD Anderson Cancer Center clinical experience. Br J Haematol. 2014 Sep; 166(6):891-901.
    View in: PubMed
    Score: 0.032
  51. c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma. Hum Pathol. 2014 Mar; 45(3):565-72.
    View in: PubMed
    Score: 0.030
  52. CXC chemokine receptor 4 expression, CXC chemokine receptor 4 activation, and wild-type nucleophosmin are independently associated with unfavorable prognosis in patients with acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2013 Dec; 13(6):686-92.
    View in: PubMed
    Score: 0.030
  53. Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases. Am J Surg Pathol. 2013 Aug; 37(8):1290-7.
    View in: PubMed
    Score: 0.030
  54. Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma. Mod Pathol. 2013 Oct; 26(10):1338-45.
    View in: PubMed
    Score: 0.029
  55. Potential therapeutic biomarkers in plasma cell myeloma: a flow cytometry study. Cytometry B Clin Cytom. 2013 Jul-Aug; 84(4):222-8.
    View in: PubMed
    Score: 0.029
  56. Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol. 2013 Jan; 37(1):14-23.
    View in: PubMed
    Score: 0.029
  57. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study. Hum Pathol. 2013 Jan; 44(1):110-21.
    View in: PubMed
    Score: 0.028
  58. High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis. Histopathology. 2012 Nov; 61(5):945-54.
    View in: PubMed
    Score: 0.028
  59. Immunoglobulin gamma heavy chain gene with somatic hypermutation is frequently expressed in acute myeloid leukemia. Leukemia. 2013 Jan; 27(1):92-9.
    View in: PubMed
    Score: 0.028
  60. Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma. J Clin Pathol. 2012 Sep; 65(9):823-9.
    View in: PubMed
    Score: 0.027
  61. Advances in the molecular pathobiology of B-lymphoblastic leukemia. Hum Pathol. 2012 Sep; 43(9):1347-62.
    View in: PubMed
    Score: 0.027
  62. Usefulness of flow cytometric immunophenotyping for bone marrow staging in patients with mantle cell lymphoma after therapy. Am J Clin Pathol. 2012 Apr; 137(4):634-40.
    View in: PubMed
    Score: 0.027
  63. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases. Hum Pathol. 2012 Sep; 43(9):1436-43.
    View in: PubMed
    Score: 0.027
  64. Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related? Haematologica. 2012 Jun; 97(6):919-25.
    View in: PubMed
    Score: 0.027
  65. Residual monotypic plasma cells in patients with waldenstrom macroglobulinemia after therapy. Am J Clin Pathol. 2011 Mar; 135(3):365-73.
    View in: PubMed
    Score: 0.025
  66. Expression of serine 194-phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non-Hodgkin lymphomas. Hum Pathol. 2011 Aug; 42(8):1117-24.
    View in: PubMed
    Score: 0.025
  67. Plasmablastic lymphoma involving the penis: a previously unreported location of a case with aberrant CD3 expression. Pathology. 2011 Jan; 43(1):54-7.
    View in: PubMed
    Score: 0.025
  68. Clonal relationship of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue involving different sites. Am J Clin Pathol. 2010 Jul; 134(1):112-8.
    View in: PubMed
    Score: 0.024
  69. Immunohistochemical profile and fluorescence in situ hybridization analysis of diffuse large B-cell lymphoma in northern China. Arch Pathol Lab Med. 2010 May; 134(5):759-65.
    View in: PubMed
    Score: 0.024
  70. Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome. Am J Clin Pathol. 2009 May; 131(5):647-55.
    View in: PubMed
    Score: 0.022
  71. Flow cytometric immunophenotyping of anaplastic large cell lymphoma. Arch Pathol Lab Med. 2009 Jan; 133(1):49-56.
    View in: PubMed
    Score: 0.022
  72. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders. Am J Surg Pathol. 2007 Mar; 31(3):447-53.
    View in: PubMed
    Score: 0.019
  73. Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma. Mod Pathol. 2007 Jan; 20(1):1-7.
    View in: PubMed
    Score: 0.019
  74. Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation. Ann Diagn Pathol. 2006 Oct; 10(5):263-8.
    View in: PubMed
    Score: 0.019
  75. Myeloid sarcoma of the urinary bladder and epididymis as a primary manifestation of acute myeloid leukemia with inv(16). Arch Pathol Lab Med. 2006 Jun; 130(6):862-6.
    View in: PubMed
    Score: 0.018
  76. Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenstr?m macroglobulinemia and does not correlate with p65 NF-kappaB activation. Mod Pathol. 2006 Jul; 19(7):891-8.
    View in: PubMed
    Score: 0.018
  77. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases. Am J Clin Pathol. 2005 Nov; 124(5):807-14.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.